Scarica l'app Stockscreener
26.69
0.98%
0.26
Dopo l'orario di chiusura:
26.28
-0.41
-1.54%
Zymeworks Inc. Borsa (ZYME) Ultime notizie
How higher bond yields impact Zymeworks Inc. (ZA8) stockPortfolio Update Report & Weekly Setup with ROI Potential - Newser
Is Zymeworks Inc. (ZA8) stock cheap vs fundamentalsPortfolio Value Report & Long Hold Capital Preservation Tips - Newser
What technical patterns form on Zymeworks Inc. (ZA8) stock chartsWeekly Gains Summary & Short-Term Swing Trade Alerts - Newser
Is Zymeworks Inc. (ZA8) stock considered safe havenInsider Selling & AI Powered Market Trend Analysis - Newser
Will Zymeworks Inc. (ZA8) stock maintain strong growth2025 Earnings Impact & Safe Capital Allocation Plans - Newser
Zymeworks to Showcase Innovative Biotherapeutics at Upcoming Conferences - MSN
Citizens Initiates Coverage of Zymeworks (ZYME) with Market Outperform Recommendation - Nasdaq
How Zymeworks Inc. (ZA8) stock performs in volatility spikesJuly 2025 Gainers & Verified Technical Signals - Newser
Zymeworks Announces Participation in Upcoming Conferences - The Manila Times
Zymeworks Inc. Announces Participation in ASCO GI and J.P. Morgan Healthcare Conference, Highlighting Advances in HER2-Driven Gastrointestinal Cancers and Novel Drug Developments - Quiver Quantitative
Is Zymeworks Inc. (ZA8) stock supported by strong fundamentalsAnalyst Upgrade & Accurate Intraday Trade Tips - Newser
Universal Beteiligungs und Servicegesellschaft mbH Takes Position in Zymeworks Inc. $ZYME - MarketBeat
Zymeworks (ZYME) Could Find a Support Soon, Here's Why You Should Buy the Stock Now - MSN
Is Zymeworks Inc a good long term investmentMarket Capitalization Trends & Join a Community of Smart Investors - earlytimes.in
Zymeworks Inc. $ZYME Stock Position Lifted by Tejara Capital Ltd - MarketBeat
Zymeworks (ZYME) Is Up 13.8% After Positive Zanidatamab Trial and Share Buyback PlanWhat's Changed - simplywall.st
Zymeworks (NASDAQ:ZYME) Stock Price Up 8%Time to Buy? - MarketBeat
Zymeworks (NYSE:ZYME) Trading Up 6.1%Here's Why - MarketBeat
Zymeworks Stock Sees Surge In Retail Chatter After Royalty Pivot, Cancer Trial Win Sparks Target Price Hikes - MSN
Zymeworks (NYSE:ZYME) Hits New 1-Year HighTime to Buy? - MarketBeat
A Look at Zymeworks (ZYME) Valuation Following $125M Buyback and Positive Zanidatamab Phase 3 Results - Sahm
Zymeworks Inc. (NYSE:ZYME) Q1 2025 Earnings Call Transcript - MSN
Zymeworks to Engage in Key Investor Conferences - MSN
Zymeworks stock hits 52-week high at 26.2 USD By Investing.com - Investing.com Nigeria
Zymeworks (NYSE:ZYME) Sees Unusually-High Trading VolumeHere's What Happened - MarketBeat
Zymeworks (NASDAQ:ZYME) Sees Large Volume IncreaseHere's Why - MarketBeat
Zymeworks stock hits 52-week high at 26.2 USD - Investing.com
Zymeworks Inc.Common Stock (Nasdaq:ZYME) Stock Quote | PRN_FinancialWrapper | PR Newswire - Markets Financial Content
Zymeworks Announces Participation in Upcoming Investor Conferences - lelezard.com
Shareholder Miller Files To Sell 118,000 Of Zymeworks Inc [ZYME] - TradingView
Hillsdale Investment Management Inc. Lowers Stake in Zymeworks Inc. $ZYME - MarketBeat
Zymeworks Inc. Management to Participate in Upcoming Investor Conferences in Miami - Quiver Quantitative
Zymeworks (NASDAQ: ZYME) to Join Evercore, Citi 2025 Healthcare Conferences - Stock Titan
Zymeworks wanted to be Canada’s first Big Pharma. Despite two blockbusters-in-the-making, that’s no longer the plan - The Globe and Mail
Zymeworks Inc. (NASDAQ:ZYME) Given Average Recommendation of "Buy" by Analysts - MarketBeat
Press Release: Zymeworks Announced Positive Phase 3 HERIZON-GEA-01 Results - Oncodaily
Zymeworks Shifts To Royalty-Driven Model From Licensed Drugs, Approves $125M Buyback Plan - Stocktwits
Shareholder Gallagher Files To Sell 105,000 Of Zymeworks Inc [ZYME] - TradingView
B. Riley Securities Reiterates Zymeworks (ZYME) Buy Recommendation - Nasdaq
Zymeworks (NASDAQ:ZYME) Shares Up 5.5%What's Next? - MarketBeat
Zymeworks (NYSE:ZYME) Stock Price Up 5.4%Here's What Happened - MarketBeat
ZYMEZymeworks BC Inc Stock Price and Quote - Finviz
Zymeworks (ZYME) Gets a Rating Reiteration and Price Target Boos - GuruFocus
Zymeworks: Adjusting My Levels After Ziihera’s Phase III Data For GEA (NASDAQ:ZYME) - Seeking Alpha
How Zymeworks Inc. (ZA8) stock behaves in tightening cyclesShare Buyback & Stock Portfolio Risk Management - newser.com
Is Zymeworks Inc. stock a contrarian buySell Signal & Real-Time Buy Zone Alerts - newser.com
1.44%
0.91%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):